Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

306 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
Kline J, Subbiah S, Lazarus HM, van Besien K. Kline J, et al. Among authors: van besien k. Bone Marrow Transplant. 2008 Mar;41(6):505-13. doi: 10.1038/sj.bmt.1705931. Epub 2007 Nov 19. Bone Marrow Transplant. 2008. PMID: 18026144 Review.
Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
Körbling M, Huh YO, Durett A, Mirza N, Miller P, Engel H, Anderlini P, van Besien K, Andreeff M, Przepiorka D, Deisseroth AB, Champlin RE. Körbling M, et al. Among authors: van besien k. Blood. 1995 Oct 1;86(7):2842-8. Blood. 1995. PMID: 7545476
High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity.
van Besien K, Tabocoff J, Rodriguez M, Andersson B, Mehra R, Przepiorka D, Dimopoulos M, Giralt S, Suki S, Khouri I, et al. van Besien K, et al. Bone Marrow Transplant. 1995 Apr;15(4):549-55. Bone Marrow Transplant. 1995. PMID: 7655380
Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts.
Körbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, et al. Körbling M, et al. Among authors: van besien k. Blood. 1995 Mar 15;85(6):1659-65. Blood. 1995. PMID: 7888684
Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation.
Przepiorka D, Ippoliti C, Panina A, Goodrich J, Giralt S, van Besien K, Mehra R, Deisseroth AB, Andersson B, Luna M, et al. Przepiorka D, et al. Among authors: van besien k. Bone Marrow Transplant. 1994 Apr;13(4):461-4. Bone Marrow Transplant. 1994. PMID: 8019472
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma.
Dimopoulos MA, Alexanian R, Przepiorka D, Hester J, Andersson B, Giralt S, Mehra R, van Besien K, Delasalle KB, Reading C, et al. Dimopoulos MA, et al. Among authors: van besien k. Blood. 1993 Oct 15;82(8):2324-8. Blood. 1993. PMID: 8104539 Clinical Trial.
Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors.
Körbling M, Chan KW, Anderlini P, Seong D, Durett A, Langlinais A, Przepiorka D, Gajewski J, Miller P, Sundberg J, Alilaen P, Bojko P, Mirza N, Claxton D, van Besien K, Khouri I, Andersson B, Mehra R, Champlin R. Körbling M, et al. Among authors: van besien k. Bone Marrow Transplant. 1996 Nov;18(5):885-90. Bone Marrow Transplant. 1996. PMID: 8932841
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus.
Przepiorka D, Ippoliti C, Khouri I, Anderlini P, Mehra R, Giralt S, Gajewski J, Fritsche H, Deisseroth AB, Cleary K, Champlin R, van Besien K, Andersson B, Korbling M. Przepiorka D, et al. Among authors: van besien k. Transplantation. 1996 Dec 27;62(12):1806-10. doi: 10.1097/00007890-199612270-00022. Transplantation. 1996. PMID: 8990368
Allogeneic blood stem cell transplantation in advanced hematologic cancers.
Przepiorka D, Anderlini P, Ippoliti C, Khouri I, Fietz T, Thall P, Mehra R, Giralt S, Gajewski J, Deisseroth AB, Cleary K, Champlin R, van Besien K, Andersson B, Körbling M. Przepiorka D, et al. Among authors: van besien k. Bone Marrow Transplant. 1997 Mar;19(5):455-60. doi: 10.1038/sj.bmt.1700692. Bone Marrow Transplant. 1997. PMID: 9052911
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue.
Giralt S, Weber D, Colome M, Dimopoulos M, Mehra R, Van Besien K, Gajewski J, Andersson B, Khouri I, Przepiorka D, von Wolff B, Delasalle K, Korbling M, Seong D, Alexanian R, Champlin R. Giralt S, et al. Among authors: van besien k. J Clin Oncol. 1997 Feb;15(2):667-73. doi: 10.1200/JCO.1997.15.2.667. J Clin Oncol. 1997. PMID: 9053492 Clinical Trial.
306 results
Jump to page
Feedback